Real-time PCR analysis determined that the downstream targets of FOXO3a, including cell-cycle inhibitors p21Cip1 and p27Kip1 were significantly downregulated, while the regulator cyclin D1 was upregulated in miR-96 transfected breast cancer cells. This evidence concerns the gene FOXO3 and breast carcinoma.